Mercia AM secures £207m in British Business Bank contracts for Midlands investments February 29, 2024 The specialist asset manager will be managing the Midlands Engine Investment II funds, after winning the procurement process.
House sales fall to lowest level since 2013 February 29, 2024 Residential property sales in January fell to their lowest level since 2013, according to the latest government figures.
Serco announces buyback and dividend hike as firm reaps the rewards from government contracts February 29, 2024 Asset manager and warehouse developer Segro made a profit during the full year, helped by securing lucrative government contracts.
Met Police missed multiple opportunities to stop Sarah Everard’s killer, review finds February 29, 2024 The Met Police missed multiple opportunities to stop Sarah Everard’s killer Wayne Couzens, a new report into the force’s failings has found.
Metro Bank brings in Barclays executive as new CFO amid major restructuring February 29, 2024 Metro Bank has appointed Barclays executive Marc Page as its new chief financial officer as the lender undergoes a major restructuring designed to shore up its balance sheet.
Spring Budget 2024: Hunt considering scrapping non-dom rules to fund tax cuts February 29, 2024 With less than a week to go until next week's Budget, the Chancellor is looking for extra sources of revenue to fund his tax-cutting agenda.
Meta faces European complaints over ‘gargantuan’ data collection February 29, 2024 Consumer groups have criticised Meta's ad-free offerings, which they say leaves users with an “unfair ‘pay-or-consent’ choice” in the face of mass data collection.
Ex-Chancellor Philip Hammond appointed as chair of fintech Railsr February 29, 2024 Former Chancellor Philip Hammond has been appointed as the chair of Railsr, a year after the embedded banking platform was rescued from collapse.
Building materials firm CRH hits record high after announcing new £236m buyback February 29, 2024 CRH switched its primary listing from London to New York in September
GSK: Cancer claims plague pharma giant as it settles another Zantac case February 29, 2024 GSK has reached another confidential settlement in a Californian lawsuit that had alleged its best-selling indigestion drug, Zantac, was carcinogenic.